Summary & Overview
HCPCS M0076: Prolotherapy Injection Therapy
HCPCS Level II code M0076 denotes prolotherapy, a therapeutic injection procedure used to stimulate soft-tissue healing and reduce musculoskeletal pain. Nationally, this code matters because prolotherapy is an outpatient, office-based interventional treatment increasingly considered in conservative management pathways for chronic tendon, ligament, and joint conditions. Proper coding ensures clinical intent is captured and supports consistent claims processing across payers.
Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations and payer-specific handling, benchmark references where available, and clinical context that clarifies when prolotherapy is billed versus other injection therapies. The publication outlines common modifiers associated with this service and highlights areas where policy updates or prior authorization requirements may affect utilization and reimbursement. The summary also points to coding nuances relevant to billing staff and revenue cycle teams, and indicates where input data was not provided.
Billing Code Overview
HCPCS Level II code M0076 represents Prolotherapy, a regenerative injection procedure intended to stimulate healing of ligaments, tendons, or joint structures. The service type is therapeutic injection for musculoskeletal pain and tissue repair. The typical site of service for this procedure is outpatient clinic or physician office settings where interventional musculoskeletal treatments are provided.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient for M0076 (Prolotherapy) is an adult with chronic, focal musculoskeletal pain—commonly axial or peripheral joint pain—who has failed conservative therapies (rest, physical therapy, NSAIDs) over several months. For example, a 48-year-old patient presents with six months of lateral knee pain after a meniscal strain, ongoing despite structured rehabilitation and intermittent analgesics. Examination shows localized joint-line tenderness with ligamentous laxity but no radiographic indication for immediate surgery. After informed consent, the patient is scheduled for outpatient prolotherapy.
The clinical workflow: the patient checks in to an ambulatory surgical or office-based procedure suite. The provider (typically a sports medicine physician, physiatrist, or pain management specialist) reviews history, documents prior conservative care, and confirms site and indication. The procedure is performed under sterile conditions with local anesthesia; multiple injections of a proliferant solution are delivered to periarticular ligaments, tendons, or joint capsule under palpation or ultrasound guidance. Post-procedure instructions include activity modification, analgesic plan, and a follow-up schedule. Billing uses M0076 for the prolotherapy service, with appropriate modifier(s) applied when clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |